Novo Nordisk A/S – Reduction of the share capital
Bagsværd, Denmark, 27 April 2021 – At Novo Nordisk’s Annual General Meeting on 25 March 2021, it was decided to reduce the company’s B share capital from DKK 362,512,800 to DKK 354,512,800 by cancellation of part of the company’s portfolio of own B shares equal to a nominal value of DKK 8,000,000 divided into 40,000,000 B shares of DKK 0.20 each.
Today, Novo Nordisk has registered the implementation of the reduction of the share capital with the Danish Business Authority and cancelled B shares at a nominal value of DKK 8,000,000. After the reduction of the share capital, the company’s share capital is nominally DKK 462,000,000, which is divided into an A share capital of nominally DKK 107,487,200 and a B share capital of nominally DKK 354,512,800.
The reduction of the share capital will not affect Novo Nordisk’s share repurchase programme which will continue as previously announced.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. Novo Nordisk employs about 45,000 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com,Facebook, Twitter, LinkedIn, YouTube.
Further information
| Media: | ||
| Mette Kruse Danielsen | +45 3079 3883 | mkd@novonordisk.com |
| Michael Bachner (US) | +1 609 664 7308 | mzyb@novonordisk.com |
| Investors: | ||
| Daniel Muusmann Bohsen | +45 3075 2175 | dabo@novonordisk.com |
| Valdemar Borum Svarrer | +45 3079 0301 | jvls@novonordisk.com |
| Ann Søndermølle Rendbæk | +45 3075 2253 | arnd@novonordisk.com |
| Mark Joseph Root | +45 3079 4211 | mjhr@novonordisk.com |
| Kristoffer Due Berg (US) | +1 609 235 2989 | krdb@novonordisk.com |
Company announcement No. 27 / 2021
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Orion Group Interim Report January–March 202425.4.2024 11:00:00 CEST | Press release
ORION CORPORATION INTERIM REPORT 1-3/2024 25 APRIL 2024 at 12:00 EEST Orion Group Interim Report January–March 2024 Net sales totalled EUR 308.5 (January–March 2023: 277.9) million Operating profit was EUR 56.0 (55.5) millionBasic earnings per share were EUR 0.31 (0.31)Cash flow from operating activities per share was EUR 0.78 (0.03) The outlook for 2024 has been specified regarding operating profit: Operating profit is estimated to be EUR 280 million to EUR 310 million. Previously operating profit was estimated to be EUR 270 million to EUR 310 million. Key figures 1-3/241-3/23Change %1-12/23 Net sales, EUR million 308.5 277.9 +11.0% 1,189.7 EBITDA, EUR million 68.5 67.7 1.2% 326.4 % of net sales 22.2% 24.4% 27.4% Operating profit, EUR million 56.0 55.5 +1.0% 274.9 % of net sales 18.2% 20.0% 23.1% Profit before taxes, EUR million 54.9 55.1 -0.4% 271.9 % of net sales 17.8% 19.8% 22.9% Profit for the period, EUR million 43.8 43.8 -0.1% 216.8 % of net sales 14.2% 15.8% 18.2% Research and
Delårsrapport 1. kvartal 202425.4.2024 10:48:56 CEST | pressemeddelelse
Vedlagt følger delårsrapport for 1. kvartal 2024 for DLR Kredit A/S. Vedhæftet fil DLR Kredit delårsrapport 1. kvartal 2024
Correction: DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 202425.4.2024 10:45:00 CEST | Press release
Dovre Group Plc Stock exchange release April 25, 2024, at 9.15 a.m. DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2024 Significant write-down of a single renewable project led to a negative operating profit Correction: PDF attachments have been added. Dovre Group Plc issues today a trading statement for the three months ended on March 31, 2024.The figures presented in this trading statement are not audited. Last year’s corresponding period in parentheses. January – March 2024 Net sales EUR 42.3 (45.8) million – decrease 7.6% Project Personnel: net sales EUR 25.2 (24.8) million – increase 1.7%Consulting: net sales EUR 3.6 (5.1) million – decrease 29.6%Renewable Energy: net sales EUR 13.5 (15.9) million - decrease 15.1%EBITDA EUR -4.6 (1.9) million Operating result EUR -4.9 (1.7) million Result before tax EUR -5.1 (1.5) million Result for the shareholders of the parent company EUR -2.4 (1.0) millionEarnings per share EUR -0.023 (0.010) Net cash flow from operating activities EUR -1
IBFD Travel Grant Opens Doors for International Tax Law Researchers25.4.2024 10:00:00 CEST | Press release
IBFD is excited to announce the opening of applications for its third annual Travel Grant for International Tax Law Research. This prestigious grant aims to support students worldwide who are conducting research in tax law, international tax law or tax history AMSTERDAM, April 25, 2024 (GLOBE NEWSWIRE) -- Recognizing the financial challenges associated with travel and accommodation, IBFD is committed to bridging the gap and providing students with unique research opportunities. “We understand the financial burden that students face when it comes to accessing resources and networking with experts,” says Belema R. Obuoforibo, Director of the IBFD Knowledge Centre and Executive Board Member. “Through this grant, we aim to open doors for a wider range of students, enabling them to benefit from our library’s exceptional resources and connect with our esteemed tax law experts.” The IBFD Travel Grant is open to undergraduate, graduate and postgraduate students from any country. While the exac
Trakx launches a new product: Trakx USDc Earn CTI powered by OpenTrade25.4.2024 10:00:00 CEST | Press release
Paris, 25 April 2024, 10:00AM CET: Trakx, an emerging global fintech company providing thematic Crypto Tradable Indices (“CTIs”), today announced the launch of the Trakx USDc Earn CTI powered by OpenTrade that is designed to allow users to easily generate high risk-adjusted returns on their USDc backed by US Treasury Bill yields. With the USDc Earn CTI, Trakx offers a unique instrument that seamlessly earns US Treasury Bills (T-Bills) like returns, while the assets are securely managed through OpenTrade’s bankruptcy remote structure. USDc holders on Trakx can now maximize the value of their USDC holdings by investing in Trakx USDc Earn CTI to earn stable, predictable yield, backed by real world financial assets, all through the existing Trakx interface.The product will be available as a standard CTI on the Trakx platform but can also be customised based on specific needs and requirements. Trakx’s partnership with OpenTrade is a case study in how France is emerging as a regional hub for